Diagnostics News and Research

RSS

OraSure registers $3.5 million net loss for full year 2010

OraSure Technologies, Inc., a market leader in oral fluid diagnostics, today announced revenues of $75.0 million and $18.8 million for the year and quarter ended December 31, 2010, respectively. This compares to revenues of $77.0 million and $20.9 million for the year and quarter ended December 31, 2009.

10 Feb 2011

No effort for ensuring continuity of supports and services as ASD children age into adulthood: Study

What happens to young adults with autism spectrum disorders (ASDs) once they graduate high school and are no longer entitled to services?

9 Feb 2011

Minnetronix introduces new Cognita remote medical device monitoring and intelligence system

Minnetronix, a provider of award-winning product design, development and manufacturing services to the medical device and life science marketplaces, is pleased to announce the introduction of its latest product offering: the Minnetronix® Cognita™ System. The system will be debuted at the Medical Design & Manufacturing West Expo on February 8-10, in Anaheim, California.

9 Feb 2011

USPTO issues patent for Metabolon's UHPLC/MSn-based analytical platform

Metabolon, the leader in metabolomics, biomarker discovery and analysis, announced today the grant of US Patent No. 7,884,318 entitled "Systems, Methods, and Computer-Readable Medium for Determining Composition of Chemical Constituents in a Complex Mixture".

8 Feb 2011

Abbott's Ibis, PLEX-ID technologies identify causative organism of plague in Afghanistan

Today, at the American Society for Microbiology Conference on Biodefense and Emerging Diseases, scientists from Abbott Molecular presented data showing the unique power of the company's Ibis technology to identify and further characterize unknown disease-causing pathogens to help aid in the bioforensic analysis of pandemic outbreaks.

8 Feb 2011

Cleveland Clinic, JumpStart Ventures invest $500,000 in SironRX Therapeutics

JumpStart Ventures, the non-profit that invests in and partners with innovative, early-stage companies in Northeast Ohio, and Cleveland Clinic, announced a combined investment commitment of $500,000 in SironRX Therapeutics, Inc. The Cleveland-based company is developing a topical therapy to enhance healing of and decrease scar formation in wounds.

8 Feb 2011

Luminex 2010 revenue increases 17% to $141.6 million

Luminex Corporation today announced financial results for the fourth quarter and year ended December 31, 2010. Recent

From Luminex 8 Feb 2011

Particle Sciences announces strategic alliance with HORIBA Instruments

Particle Sciences, Inc., a leading pharmaceutical CRO, is pleased to announce the establishment of a strategic alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan.

8 Feb 2011

Breakthrough in Thermal Gradient's fast PCR technology for molecular diagnostics

Thermal Gradient, a Rochester, NY biotech company, announces a breakthrough in its fast PCR technology for molecular diagnostics. PCR is the preferred critical step in virtually all forms of DNA testing.

8 Feb 2011

Abbott launches PLEX-ID Biothreat Assay to detect, distinguish 17 different pathogens

Abbott announced today that it has introduced the PLEX-ID Biothreat Assay, which is designed to detect and distinguish 17 different biothreat pathogens.

7 Feb 2011

PharmaMar initiates PM060184 Phase I clinical trial in patients with solid tumors

PharmaMar SA has announced the commencement of a Phase I clinical trial with PM060184 for patients with solid tumors. PM060184 is a marine-derived, synthetically-produced compound which has shown strong in vitro and in vivo antitumor activity and a favorable safety profile in preclinical toxicology studies. PM060184 is PharmaMar's sixth compound in clinical development.

7 Feb 2011

XDx and LabCorp enter non-hospital provider agreement for AlloMap molecular expression tests

XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests to monitor immune-mediated conditions, today announced that it has entered into a multi-year agreement with Laboratory Corporation of America Holdings to provide heart transplant patients eligible for XDx's AlloMap® test with the convenience of having their blood drawn at participating LabCorp sites across the United States.

7 Feb 2011

iBridge Network announces tangible proof points for innovation, entrepreneurship

The recent launch of the 'Start-Up America Partnership', a coordinated public/private effort to celebrate, inspire and accelerate innovation and entrepreneurship and support the White House's Start-Up America initiative, validates the importance of stimulating economic growth, creating quality jobs, and building the new industries of the 21st Century.

5 Feb 2011

NCC, BD to implement cervical cancer early detection program for underserved women in Peru

The National Cancer Coalition and BD (Becton, Dickinson and Company), a leading global medical technology company, are pleased to announce the implementation of a cervical cancer early detection program to benefit 75,000 underserved women in Peru. With a goal to reduce the high cervical cancer mortality levels in the mountainous region surrounding Cusco, this extensive three-year program is set to conduct liquid-based cytology exams utilizing the BD SurePath™ Liquid-based Pap Test System.

From BD (Becton, Dickinson and Company) 5 Feb 2011

Roche launches cobas TaqScreen DPX Test for parvovirus B19 and hepatitis A virus

Roche announced today that the cobas® TaqScreen DPX Test for use on the cobas s 201 system is now available in the US. It is the first commercial test to quantify parvovirus B19 and detect hepatitis A virus (HAV) simultaneously in one assay in human plasma.

5 Feb 2011

Endocyte prices initial public offering

Endocyte, Inc., a biopharmaceutical company developing targeted small molecule drug conjugates, announced today the pricing of its initial public offering of 12,500,000 shares of its common stock.

5 Feb 2011

Hologic receives FDA approval for hydroxyprogesterone caproate injection

Hologic, a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the U.S. Food and Drug Administration has approved Hologic's pharmaceutical named Makena, formerly known as Gestiva.

From Hologic, Inc. 4 Feb 2011

BG Medicine prices initial public offering of 5,000,000 shares of common stock

BG Medicine today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price of $7.00 per share, before underwriting discounts and commissions. All shares are being sold by the Company.

4 Feb 2011

Cholesterol efflux capacity may protect against heart disease: Study

The discovery that high levels of high-density lipoprotein cholesterol are associated with reduced risk of cardiovascular disease has fostered intensive research to modify HDL levels for therapeutic gain. However, recent findings have called into question the notion that pharmacologic increases in HDL cholesterol levels are necessarily beneficial to patients.

4 Feb 2011

FIND, Cepheid collaborate to develop rapid molecular test for measurement of HIV viral load

Cepheid and FIND today announced a new collaboration to accelerate the development of a rapid molecular test for the measurement of human immunodeficiency virus viral load.

3 Feb 2011

Diagnostics News and Research

OraSure registers $3.5 million net loss for full year 2010

No effort for ensuring continuity of supports and services as ASD children age into adulthood: Study

Minnetronix introduces new Cognita remote medical device monitoring and intelligence system

USPTO issues patent for Metabolon's UHPLC/MSn-based analytical platform

Abbott's Ibis, PLEX-ID technologies identify causative organism of plague in Afghanistan

Cleveland Clinic, JumpStart Ventures invest $500,000 in SironRX Therapeutics

Luminex 2010 revenue increases 17% to $141.6 million

Particle Sciences announces strategic alliance with HORIBA Instruments

Breakthrough in Thermal Gradient's fast PCR technology for molecular diagnostics

Abbott launches PLEX-ID Biothreat Assay to detect, distinguish 17 different pathogens

PharmaMar initiates PM060184 Phase I clinical trial in patients with solid tumors

XDx and LabCorp enter non-hospital provider agreement for AlloMap molecular expression tests

iBridge Network announces tangible proof points for innovation, entrepreneurship

NCC, BD to implement cervical cancer early detection program for underserved women in Peru

Roche launches cobas TaqScreen DPX Test for parvovirus B19 and hepatitis A virus

Endocyte prices initial public offering

Hologic receives FDA approval for hydroxyprogesterone caproate injection

BG Medicine prices initial public offering of 5,000,000 shares of common stock

Cholesterol efflux capacity may protect against heart disease: Study

FIND, Cepheid collaborate to develop rapid molecular test for measurement of HIV viral load

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News